BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 14984506)

  • 21. cGMP modulation therapeutics for sickle cell disease.
    Conran N; Torres L
    Exp Biol Med (Maywood); 2019 Feb; 244(2):132-146. PubMed ID: 30691292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fetal hemoglobin in sickle cell anemia: genetic determinants of response to hydroxyurea.
    Ma Q; Wyszynski DF; Farrell JJ; Kutlar A; Farrer LA; Baldwin CT; Steinberg MH
    Pharmacogenomics J; 2007 Dec; 7(6):386-94. PubMed ID: 17299377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fetal hemoglobin and F-cell responses to long-term hydroxyurea treatment in young sickle cell patients. The French Study Group on Sickle Cell Disease.
    Maier-Redelsperger M; de Montalembert M; Flahault A; Neonato MG; Ducrocq R; Masson MP; Girot R; Elion J
    Blood; 1998 Jun; 91(12):4472-9. PubMed ID: 9616141
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hydroxyurea therapy in sickle cell anemia patients aids to maintain oral fungal colonization balance.
    Salvia AC; Figueiredo MS; Braga JA; Pereira DF; Brighenti FL; Koga-Ito CY
    J Oral Pathol Med; 2013 Aug; 42(7):570-5. PubMed ID: 23278631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of hydroxyurea on immature reticulocyte fraction in sickle cell anemia.
    Bagdasaryan R; Glasser L; Quillen K; Chaves F; Xu D
    Lab Hematol; 2007; 13(3):93-7. PubMed ID: 17984040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term use of hydroxyurea for sickle cell anemia.
    Hagar W
    JAMA; 2003 Aug; 290(6):753; author reply 754. PubMed ID: 12915424
    [No Abstract]   [Full Text] [Related]  

  • 27. Epigenetic and molecular profiles of erythroid cells after hydroxyurea treatment in sickle cell anemia.
    Walker AL; Steward S; Howard TA; Mortier N; Smeltzer M; Wang YD; Ware RE
    Blood; 2011 Nov; 118(20):5664-70. PubMed ID: 21921042
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of hydroxyurea on hemoglobin F and water content in the red blood cells of dogs and of patients with sickle cell anemia.
    Orringer EP; Blythe DS; Johnson AE; Phillips G; Dover GJ; Parker JC
    Blood; 1991 Jul; 78(1):212-6. PubMed ID: 1712641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reference values and hematologic changes from birth to 5 years in patients with sickle cell disease. Cooperative Study of Sickle Cell Disease.
    Brown AK; Sleeper LA; Miller ST; Pegelow CH; Gill FM; Waclawiw MA
    Arch Pediatr Adolesc Med; 1994 Aug; 148(8):796-804. PubMed ID: 7519102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hydroxyurea differentially modulates activator and repressors of γ-globin gene in erythroblasts of responsive and non-responsive patients with sickle cell disease in correlation with Index of Hydroxyurea Responsiveness.
    Zhu X; Hu T; Ho MH; Wang Y; Yu M; Patel N; Pi W; Choi JH; Xu H; Ganapathy V; Kutlar F; Kutlar A; Tuan D
    Haematologica; 2017 Dec; 102(12):1995-2004. PubMed ID: 28971909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decrease of very late activation antigen-4 and CD36 on reticulocytes in sickle cell patients treated with hydroxyurea.
    Styles LA; Lubin B; Vichinsky E; Lawrence S; Hua M; Test S; Kuypers F
    Blood; 1997 Apr; 89(7):2554-9. PubMed ID: 9116302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of hydroxyurea and L-arginine on the production of nitric oxide metabolites in cultures of normal and sickle erythrocytes.
    Nahavandi M; Tavakkoli F; Millis RM; Wyche MQ; Habib MJ; Tavakoli N
    Hematology; 2006 Aug; 11(4):291-4. PubMed ID: 17178670
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decreased fetal hemoglobin over time among youth with sickle cell disease on hydroxyurea is associated with higher urgent hospital use.
    Green NS; Manwani D; Qureshi M; Ireland K; Sinha A; Smaldone AM
    Pediatr Blood Cancer; 2016 Dec; 63(12):2146-2153. PubMed ID: 27573582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hydroxyurea nitrosylates and activates soluble guanylyl cyclase in human erythroid cells.
    Cokic VP; Andric SA; Stojilkovic SS; Noguchi CT; Schechter AN
    Blood; 2008 Feb; 111(3):1117-23. PubMed ID: 17993617
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanism of action of hydroxyurea in the management of sickle cell anemia in adults.
    Charache S
    Semin Hematol; 1997 Jul; 34(3 Suppl 3):15-21. PubMed ID: 9317197
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hydroxyurea therapy modulates sickle cell anemia red blood cell physiology: Impact on RBC deformability, oxidative stress, nitrite levels and nitric oxide synthase signalling pathway.
    Nader E; Grau M; Fort R; Collins B; Cannas G; Gauthier A; Walpurgis K; Martin C; Bloch W; Poutrel S; Hot A; Renoux C; Thevis M; Joly P; Romana M; Guillot N; Connes P
    Nitric Oxide; 2018 Dec; 81():28-35. PubMed ID: 30342855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beneficial Effects of Soluble Guanylyl Cyclase Stimulation and Activation in Sickle Cell Disease Are Amplified by Hydroxyurea: In Vitro and In Vivo Studies.
    Ferreira WA; Chweih H; Lanaro C; Almeida CB; Brito PL; Gotardo EMF; Torres L; Miguel LI; Franco-Penteado CF; Leonardo FC; Garcia F; Saad STO; Frenette PS; Brockschnieder D; Costa FF; Stasch JP; Sandner P; Conran N
    J Pharmacol Exp Ther; 2020 Sep; 374(3):469-478. PubMed ID: 32631869
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased adhesive properties of neutrophils in sickle cell disease may be reversed by pharmacological nitric oxide donation.
    Canalli AA; Franco-Penteado CF; Saad ST; Conran N; Costa FF
    Haematologica; 2008 Apr; 93(4):605-9. PubMed ID: 18326523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantification of HBG mRNA in primary erythroid cultures: prediction of the response to hydroxyurea in sickle cell and beta-thalassemia.
    Pecoraro A; Rigano P; Troia A; Calzolari R; Scazzone C; Maggio A; Steinberg MH; Di Marzo R
    Eur J Haematol; 2014 Jan; 92(1):66-72. PubMed ID: 24112139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Individual red blood cell fetal hemoglobin quantification allows to determine protective thresholds in sickle cell disease.
    Hebert N; Rakotoson MG; Bodivit G; Audureau E; Bencheikh L; Kiger L; Oubaya N; Pakdaman S; Sakka M; Di Liberto G; Chadebech P; Vingert B; Pirenne F; Galactéros F; Cambot M; Bartolucci P
    Am J Hematol; 2020 Nov; 95(11):1235-1245. PubMed ID: 32681733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.